Related references
Note: Only part of the references are listed.(-)- Epigallocatechin-3-Gallate (EGCG) Increases the Viability of Serum-Starved A549 Cells Through Its Effect on Akt
Myung Jin Kim et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2009)
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Hyun Woo Jeong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Green Tea Catechin Controls Apoptosis in Colon Cancer Cells by Attenuation of H2O2-Stimulated COX-2 Expression via the AMPK Signaling Pathway at Low-Dose H2O2
In-Ja Park et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways
Tianpeng Zhang et al.
APOPTOSIS (2009)
Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway
Takatoshi Murase et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells
Noritaka Ohga et al.
CANCER SCIENCE (2009)
Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells
A. Peairs et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Widespread expression of inducible NOS and citrulline in lupus nephritis tissues
J. J. Bollain-y-Goytia et al.
INFLAMMATION RESEARCH (2009)
The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR
Jingjing Zhu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells
Chi-Hung Huang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytolkines in human monocytic THP-1 cells
Chi-Hao Wu et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
The AKT Axis as a Therapeutic Target in Autoimmune Diseases
Tianfu Wu et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2009)
Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury
Xia Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
T. Weichhart et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Epigallocatechin-3-Gallate Diminishes CCL2 Expression in Human Osteoblastic Cells via Up-Regulation of Phosphatidylinositol 3-Kinase/Akt/Raf-1 Interaction
Sze-Kwan Lin et al.
ARTHRITIS AND RHEUMATISM (2008)
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer
Sharmila Shankar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
A novel transcript of mouse interleukin-20 receptor acts on glomerular mesangial cells as an aggravating factor in lupus nephritis
C-C Wei et al.
GENES AND IMMUNITY (2008)
The anti-inflammatory and anti-cancer properties of epigallocatechin-3-gallate are mediated by folate cycle disruption, adenosine release and NF-κB suppression
E. Navarro-Peran et al.
INFLAMMATION RESEARCH (2008)
Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt
Bin Xing et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Differential Effects of Rapamycin in Anti-GBM Glomerulonephritis
Kathrin Hochegger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Epigallocatechin-3-O-gallate inhibits TNFα-induced monocyte chemotactic protein-1 production from vascular endothelial cells
Hee Yul Ahn et al.
LIFE SCIENCES (2008)
Rapamycin prevents the development of nephritis in lupus-pirone NZH/W F-1 mice
S. L. Lui et al.
LUPUS (2008)
Immunology in China: the past, present and future
Xuetao Cao
NATURE IMMUNOLOGY (2008)
Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
Padmalatha S. Reddy et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis
Jim C. Oates et al.
ARTHRITIS AND RHEUMATISM (2008)
The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat
Regina Vogelbacher et al.
TRANSPLANTATION (2007)
Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells
Hyun-Seuk Moon et al.
OBESITY (2007)
Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell
Hirofumi Nishikawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase
Qu Fan Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Eleutherococcus senticosus extract attenuates LPS-induced NOS expression through the inhibition of Akt and JNK pathways in murine macrophage
Chang Hwa Jung et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia
Yan Zhou et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus
Tianfu Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway
Jin-Taek Hwang et al.
CANCER LETTERS (2007)
High sirolimus levels may induce focal segmental glomerulosclerosis de novo
Emmanuel Letavernier et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
(-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells
Fulvia Farabegoli et al.
CANCER DETECTION AND PREVENTION (2007)
Prevention of murine lupus disease in (NZB x NZW)F-1 mice by sirolimus treatment
A. Ramos-Barron et al.
LUPUS (2007)
A role for transcription factor NF-κB in autoimmunity:: possible interactions of genes, sex, and the immune response
Elizabeth Dale et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2006)
EGCG protects HT-22 cells against glutamate-induced oxidative stress
Yu Fu et al.
NEUROTOXICITY RESEARCH (2006)
A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells
Michelle T. Barati et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Anti-obesity effects of green tea: From bedside to bench
S Wolfram et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus
DF Barber et al.
NATURE MEDICINE (2005)
Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells
ML Sheu et al.
CELLULAR SIGNALLING (2005)
Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy
K Nagai et al.
KIDNEY INTERNATIONAL (2005)
Estradiol-mediated endothelial nitric oxide synthase association with heat shock protein 90 requires adenosine monophosphate-dependent protein kinase
E Schulz et al.
CIRCULATION (2005)
The lipopolysaccharide-triggered mesangial transcriptome: Evaluating the role of interferon regulatory factor-1
YY Fu et al.
KIDNEY INTERNATIONAL (2005)
5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside inhibits proinflammatory response in glial cells:: A possible role of AMP-activated protein kinase
S Giri et al.
JOURNAL OF NEUROSCIENCE (2004)
The NF-kappa B pathway as a potential target for autoimmune disease therapy
S Bacher et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway
HK Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase
M Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Epigallocatechin-3-gallate selectively inhibits interleukin-1 beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes
R Singh et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2003)
Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP
J Yang et al.
NATURE STRUCTURAL BIOLOGY (2002)
Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1β-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes
S Ahmed et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Epigallocatechin-3-gallate inhibits interleukin-1β-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes -: Suppression of nuclear factor κB activation by degradation of the inhibitor of nuclear factor κB
R Singh et al.
ARTHRITIS AND RHEUMATISM (2002)
Cancer preventive effects of flavonoids - a review
L Le Marchand
BIOMEDICINE & PHARMACOTHERAPY (2002)
Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase
CM Reilly et al.
KIDNEY INTERNATIONAL (2002)
Prostaglandin J2 inhibition of mesangial cell iNOS expression
CM Reilly et al.
CLINICAL IMMUNOLOGY (2001)
Share Paper
